CoChat

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Treatment of severe refractory pruritus with fractionated plasma separation and adsorption (Prometheus)

Rifai, Kinan, Hafer, Carsten, Rosenau, Jens, Athmann, Christoph, Haller, Hermann, Peter Manns, Michael, Fliser, Danilo · 2006 · Scandinavian Journal of Gastroenterology

Abstract

OBJECTIVE: Severe pruritus is a serious complication of cholestatic liver disease. Prometheus is a recently introduced extracorporeal liver support system with direct toxin adsorption of the patient's albumin fraction (FPSA; fractionated plasma separation and adsorption). Here we report on the effect of Prometheus therapy in patients with intractable cholestatic pruritus. MATERIAL AND METHODS: Seven patients with different liver diseases and severe pruritus refractory to all medical treatment efforts for more than 4 weeks were treated with Prometheus (3-5 times, 18+/-3 h total). Pruritus intensity was assessed using the visual analogue scale (VAS; from 0 = no pruritus to 10 = unbearable pruritus), and VAS, serum bile acids and total bilirubin were evaluated directly before and after Prometheus treatment, as well as 4 weeks later. RESULTS: After Prometheus therapy, VAS values had dropped significantly from 9+/-1 to 3+/-3 (p<0.001). Likewise, serum bile acids decreased (from 248+/-192 to 101+/-85 micromol/l; p<0.03). All patients, with the exception of one with no initial bile acid elevation, reported a pronounced improvement in pruritus with Prometheus therapy, although in two anicteric patients the amelioration lasted only a few days. In the other four patients a distinct benefit was still observed 4 weeks after the treatment. CONCLUSIONS: Prometheus therapy significantly improved refractory pruritus in all patients with elevated bile acid levels, but in some patients the clinical benefit was of short duration. The clinical findings suggest that we have to better characterize those patients who might derive a long-lasting benefit from this invasive and expensive treatment.

Overview

Integrity signals

Registry

Crossref · 10.1080/00365520600610154

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 20 references

Research works printed but not linked: 1

  1. Younossi ZM, 2000, Am J Gastroenterol, 95, 497, 10.1111/j.1572-0241.2000.01774.x · doi:10.1111/j.1572-0241.2000.01774.x · Paper page

Cited by

See all 53

Metadata

Authors
Rifai, K., Hafer, C., Rosenau, J., Athmann, C., Haller, H., Peter Manns, M., & Fliser, D.
Affiliations
Medizinische Hochschule Hannover (DE)
Corresponding author
Rifai, Kinan
Venue
Scandinavian Journal of Gastroenterology
Published
2006-01
Volume
41
Issue
10
Pages
1212-1217
ISSN
  • 0036-5521 (ISSN-L)
  • 1502-7708
OpenAlex
W1976928452
Cited by
53
References
20
Citations by year
2024: 2 · 2023: 4 · 2022: 1 · 2020: 1 · 2019: 2 · 2018: 2 · 2017: 3 · 2016: 6 · 2015: 2 · 2014: 1 · 2013: 3 · 2012: 3
FWCI
3.71
Type
journal article
Language
en
Open access
closed
Locations
  • Scandinavian Journal of Gastroenterology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
Keywords
refractory pruritus, cholestatic pruritus, extracorporeal liver support, bile acid adsorption, serum bile acids, cholestatic liver disease
MeSH terms
Adsorption, Adult, Aged, Bile Acids and Salts, Bilirubin, Cholestasis, Intrahepatic, Extracorporeal Circulation, Female, Humans, Male, Middle Aged, Pruritus, Toxins, Biological

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Treatment of severe refractory pruritus with fractionated plasma separation and adsorption (Prometheus). https://app.cochat.ai/papers/10.1080/00365520600610154
The paper
Rifai, K., Hafer, C., Rosenau, J., Athmann, C., Haller, H., Peter Manns, M., & Fliser, D. (2006). Treatment of severe refractory pruritus with fractionated plasma separation and adsorption (Prometheus). Scandinavian Journal of Gastroenterology. https://doi.org/10.1080/00365520600610154

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.